BioCentury | Aug 27, 2007
Analyst Picks & Changes

Analyst picks & changes

...second FDA approvable letter for Kiacta eprodisate to treat amyloid A (AA) amyloidosis. Novelo (NVLT) Emerging Growth Capital...
BioCentury | Jun 21, 2007
Financial News

Progen raises A$34.1 million

...of 5.9 million shares at A$5.74 in a rights issue underwritten by Bell Potter and Emerging Growth Capital...
Items per page:
1 - 2 of 2
BioCentury | Aug 27, 2007
Analyst Picks & Changes

Analyst picks & changes

...second FDA approvable letter for Kiacta eprodisate to treat amyloid A (AA) amyloidosis. Novelo (NVLT) Emerging Growth Capital...
BioCentury | Jun 21, 2007
Financial News

Progen raises A$34.1 million

...of 5.9 million shares at A$5.74 in a rights issue underwritten by Bell Potter and Emerging Growth Capital...
Items per page:
1 - 2 of 2